City

Beijing (1)

Condition

Advanced Melanoma (1)

Untreated Patients (1)

Overall Status

Unknown status (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Simcere Pharmaceutical Co., Ltd (1)

Collaborator

Intervention

dacarbazine plus endostar (experimental group) (1)

dacarbazine plus placebo (control group) (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

untreated patients

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Melanoma, Untreated Patients Trial in Beijing (dacarbazine plus Endostar (Experimental group), dacarbazine plus

Unknown status

Advanced Melanoma
Untreated Patients

dacarbazine plus Endostar (Experimental group)
dacarbazine plus placebo (control group)

Beijing, Beijing, China

Beijing tumor hospital

Dec 6, 2009